2015
DOI: 10.1038/srep16043
|View full text |Cite
|
Sign up to set email alerts
|

Chronic lung infection by Pseudomonas aeruginosa biofilm is cured by L-Methionine in combination with antibiotic therapy

Abstract: Bacterial biofilms are associated with 80–90% of infections. Within the biofilm, bacteria are refractile to antibiotics, requiring concentrations >1,000 times the minimum inhibitory concentration. Proteins, carbohydrates and DNA are the major components of biofilm matrix. Pseudomonas aeruginosa (PA) biofilms, which are majorly associated with chronic lung infection, contain extracellular DNA (eDNA) as a major component. Herein, we report for the first time that L-Methionine (L-Met) at 0.5 μM inhibits Pseudomon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0

Year Published

2016
2016
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 40 publications
(36 citation statements)
references
References 60 publications
(78 reference statements)
0
36
0
Order By: Relevance
“…In addition to pH modulatory effects 83 , L-Arg also repressed genes involved in the production of insoluble EPS and bacteriocin in S. mutans , while increasing hydrogen peroxide (used against S. mutans ) production by S. gordonii 84 L-Arg reduced biomass and altered EPS architecture in S. gordonii biofilms 85 , and also destabilized multispecies oral biofilms, thus reducing viability and increasing susceptibility to cetylpyridinium chloride 86 . An alternative amino acid, L-methionine, was also identified as a promising adjuvant for treating P. aeruginosa biofilms, triggering disassembly and increasing sensitivity towards ciprofloxacin in a mouse model of chronic pneumonia, and enhancing survival of infected mice 87 . This activity was attributed to up-regulation of four different DNase genes and the subsequent degradation of eDNA in the EPS matrix, although the exact pathways that regulate this response were not determined.…”
Section: Metabolic Interferencementioning
confidence: 99%
“…In addition to pH modulatory effects 83 , L-Arg also repressed genes involved in the production of insoluble EPS and bacteriocin in S. mutans , while increasing hydrogen peroxide (used against S. mutans ) production by S. gordonii 84 L-Arg reduced biomass and altered EPS architecture in S. gordonii biofilms 85 , and also destabilized multispecies oral biofilms, thus reducing viability and increasing susceptibility to cetylpyridinium chloride 86 . An alternative amino acid, L-methionine, was also identified as a promising adjuvant for treating P. aeruginosa biofilms, triggering disassembly and increasing sensitivity towards ciprofloxacin in a mouse model of chronic pneumonia, and enhancing survival of infected mice 87 . This activity was attributed to up-regulation of four different DNase genes and the subsequent degradation of eDNA in the EPS matrix, although the exact pathways that regulate this response were not determined.…”
Section: Metabolic Interferencementioning
confidence: 99%
“…Several reports displayed that both AZM and BER could target efflux pumps (MexXY) [40, 45] and eDNA [26, 30] in PA. However, macrolides were supposed to be difficult of diffusion across the outer membrane of most gram-negative bacteria [46].…”
Section: Discussionmentioning
confidence: 99%
“…The medium free of agent was set as control. The biofilm formation (%) were measured by crystal violet (CV) staining, which was equal to OD 545 of sample treated/OD 545 of control [30]. …”
Section: Methodsmentioning
confidence: 99%
“…The highest dose‐specific inhibition of biofilm growth was observed with 0.5 μM l ‐methionine (OD 590 : 0.29 ± 0.03), significantly lower than controls (OD 590 : 0.41 ± 0.06; p = 0.003; Fig. ), consistent with previous studies . Anti‐biofilm activity diminished as the concentration of l ‐methionine increased from 2.5 μM (OD 590 : 0.307 ± 0.023; p = 0.009) to 5 μM (OD 590 : 0.39 ± 0.033; p = 0.9).…”
Section: Resultsmentioning
confidence: 99%
“…To treat bacterial biofilms without using such intense drug therapies, alternative approaches with unconventional agents that disrupt or inhibit biofilms have garnered significant attention . Amino acids, such as d ‐amino acids and l ‐tryptophan, are commonly secreted by biofilms during later stages of development and have been among several agents recently studied for their potential anti‐biofilm activity . d ‐Amino acids are effective at disassembling existing biofilms, whereas l ‐ tryptophan inhibits the formation of biofilms.…”
mentioning
confidence: 99%